v3.26.1
Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 73,309 $ 41,333
Research and development credits 7,975 7,975
Stock-based compensation 1,122 1,062
Operating lease liabilities 7,989 9,184
Capitalized research & experimental expenditures 825 24,975
Deferred revenue 3,132 3,234
Other 467 785
Total gross deferred tax assets 94,819 88,548
Less: valuation allowance (91,767) (84,810)
Total deferred tax assets 3,052 3,738
Operating lease right-of-use assets (3,052) (3,738)
Total deferred tax liabilities $ (3,052) $ (3,738)